{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:21:09Z","timestamp":1760188869525},"reference-count":23,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2006,7,11]],"date-time":"2006-07-11T00:00:00Z","timestamp":1152576000000},"content-version":"vor","delay-in-days":7162,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American J Hematol"],"published-print":{"date-parts":[[1986,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>One\u2010hundred thirteen adults and children with hemophilia or other congenital bleeding disorders were vaccinated against the hepatitis B virus. Each patient was given three subcutaneous injections of the vaccine at monthly intervals and then a fourth booster dose 14 months after the first. The vaccine was highly immunogenic, since 111 of 113 patients (98%) produced anti\u2010HBs (10 mlU\/ml or more). After the first three vaccine doses and after the booster dose, ten anti\u2010LAV\/HTLV\u2010III\u2010positive hemophiliacs produced anti\u2010HBs but had a lower average titer than anti\u2010LAV\/HTLV\u2010III\u2010negative hemophiliacs. Of the 23 patients treated with concentrates in the 15 month postvaccination period only, none acquired HBV infection. Of the 50 patients treated with concentrates also in the 6 month prevaccination period, one developed hepatitis B. In summary, the vaccine was highly immunogenic in both children and adults with hemophilia; anti\u2010LAV\/HTLV\u2010III\u2010positive patients responded to the vaccine, but the average anti\u2010HBs response was lower; no case of hepatitis B occurred in patients treated with concentrates only in the postvaccination period.<\/jats:p>","DOI":"10.1002\/ajh.2830230406","type":"journal-article","created":{"date-parts":[[2007,2,21]],"date-time":"2007-02-21T10:38:51Z","timestamp":1172054331000},"page":"339-345","source":"Crossref","is-referenced-by-count":27,"title":["Hepatitis B vaccination of 113 hemophiliacs: Lower antibody response in anti\u2010LAV\/HTLV\u2010III\u2010positive patients"],"prefix":"10.1002","volume":"23","author":[{"given":"A. R.","family":"Zanetti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. M.","family":"Mannucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Tanzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. A.","family":"Moroni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"De Paschale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Morfini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Carnelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. C.","family":"Tirindelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"De Biasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Ciavarella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"De Rosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Rodeghiero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,7,11]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.287.6407.1737"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-98-3-403"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(84)91942-1"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-103-5-723"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/145.1.18"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1982.22583017454.x"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/150.2.250"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(85)90055-8"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(85)92954-X"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-103-2-226"},{"issue":"40","key":"e_1_2_1_12_2","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1600-0609.1984.tb02580.x","article-title":"Use of HBV vaccine in hemophiliacs","volume":"33","author":"Gazangel C","year":"1984","journal-title":"Scand J Haematol"},{"issue":"40","key":"e_1_2_1_13_2","first-page":"317","article-title":"Immunization of hemophiliacs against hepatitis","volume":"33","author":"Hedner U","year":"1984","journal-title":"B. Scand J Haematol"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(85)80168-2"},{"key":"e_1_2_1_15_2","first-page":"599","volume-title":"Viral Hepatitis and Liver Disease. 1984 International Symposium","author":"Krugman S","year":"1984"},{"key":"e_1_2_1_16_2","first-page":"451","volume-title":"Viral Hepatitis. 1981 International Symposium","author":"Hollinger FB","year":"1982"},{"key":"e_1_2_1_17_2","first-page":"275","volume-title":"Viral Hepatitis and Liver Disease. 1984 International Symposium","author":"Stevens CE","year":"1984"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.1890180405"},{"key":"e_1_2_1_19_2","article-title":"Hepatitis B vaccine: Evidence confirming lack of AIDS transmission","volume":"685","author":"Centers for Disease Control","year":"1984","journal-title":"Morbid Mortal Weekly Rep"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00915797"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198308253090803"},{"issue":"40","key":"e_1_2_1_22_2","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1600-0609.1984.tb02576.x","article-title":"Review of the transmission of hepatitis by clotting factor concentrates","volume":"33","author":"Tabor E","year":"1984","journal-title":"Scand J Haematol"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840050606"},{"key":"e_1_2_1_24_2","first-page":"127","volume-title":"Viral Hepatitis and Delta Infection","author":"Zanetti AR","year":"1983"}],"container-title":["American Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fajh.2830230406","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ajh.2830230406","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,22]],"date-time":"2023-10-22T17:53:24Z","timestamp":1697997204000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ajh.2830230406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1986,12]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1986,12]]}},"alternative-id":["10.1002\/ajh.2830230406"],"URL":"https:\/\/doi.org\/10.1002\/ajh.2830230406","archive":["Portico"],"relation":{},"ISSN":["0361-8609","1096-8652"],"issn-type":[{"value":"0361-8609","type":"print"},{"value":"1096-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[1986,12]]}}}